Institut Curie;Universite de Montpellier 2;Centre National de la Recherche Scientifique;Societe Splicos
发明人:
Tazi, Jamal,Mahuteau, Florence,Najman, Romain
申请号：
AU2010258295
公开号：
AU2010258295A1
申请日:
2010.06.14
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The present invention relates to compound Formula (I) wherein: Formula (II) means a pyridazine, a pyrimidine or a pyrazine group, R independently represent a hydrogen atom, a halogen atom or a group chosen among a CN group, a hydroxyl group, a COOR group, a (C-C)fluoroalkyl group, a (C-C)fluoroalkoxy group, a NO group, a NRR group, a (C-C)alkoxy group, a phenoxy group and a (C-C)alkyl group, said alkyl being optionally mono-substituted by a hydroxyl group, n is 1, 2 or 3, n is 1 or 2, R is a hydrogen atom, a halogen atom or a group chosen among a (C-C)alkyl group,, a hydroxyl group, a COOR group, a NO group, a NRR group, a morpholinyl or a morpholino group, a N-methylpiperazinyl group, a (C-C)fluoroalkyl group, a (C-C)alkoxy group and a CN group, Z is N or C, Y is N or C, X is N or C, W is N or C, T is N or C, U is N or C, for use as an agent for preventing, inhibiting or treating AIDS. Some of said compounds are new and also form part of the invention.
